RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. BioProcess360 Partners
B

BioProcess360 Partners portfolio

BioProcess360 Partners has 1 portfolio company on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $8.86M.
Latest deal: Abselion · Dec 4, 2024.
About this page

Its most recent investment on record is Abselion's $8.86M Series A round in December 2024, alongside UNTITLED, R42 Group, Business Growth Fund and 1 other. That company is in Health and bio.

What BioProcess360 Partners invests in

How BioProcess360 Partners invests

StageDealsCapital in rounds
Series A 1 100%$8.86M

BioProcess360 Partners portfolio companies

CompanyRound with BioProcess360 PartnersTotal raisedLatest raise
AAbselion
Health and bio
Series A · $8.86M$8.86MDec 4, 2024
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name BioProcess360 Partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists BioProcess360 Partners, which is a subset of its real portfolio. API: /api/v1/investors/bioprocess360-partners (get a free API key). More: the most active VC firms and new venture capital funds.